Non-Profits, Investors Worry About Proposed Washington State Tax Surcharge Increase

Leroy Hood called the bill short-sighted and said that over the long-term it could potentially reduce the attractiveness of starting up companies in the Seattle area.

People In The News

Affymetrix and Osmetech named new CFOs this week, while Agilent promoted Rick Burdsall to the newly created position of chief infrastructure officer, and Shankar Balasubramanian has won the Innovator of the Year award from the UK's Biotechnology and Biological Sciences Research Council; plus more.

In Brief This Week: Promega; Sigma-Aldrich; HistoRx; Med fusion

In Brief This Week is a Friday column containing news items that our readers may have missed during the week.

NCI to Fund Molecular Research into Cancer-Fighting Foods

The research may use genomic, proteomic, and other methods to understand the molecular reasons why some foods inhibit or suppress cancer.

Osmetech Files for US IPO; Creates US Parent

The British molecular diagnostics firm intends to raise around $40 million in a US IPO and will be based in the US as a wholly-owned subsidiary of GenMark Diagnostics.

Osmetech's 2009 Revenues Rise 81 Percent

The British molecular diagnostics firm's revenues rose on increased sales of its cystic fibrosis genotyping test and a warfarin sensitivity test.

BGI, US Team Launches Symbiont Genome Project

Chinese and American researchers plan to sequence and compare the genomes of the sea slug, Elysia chlorotica, and Vaucheria litorea, an algal species from which the slug has taken chloroplast biosynthesis genes.

Australian Research Institute Begins First Phase of Major Expansion

The Prince of Wales Medical Research Institute said it plans to start construction immediately on the first phase of a project intended to greatly expand its space and facilitate research into brain injury and Alzheimer's and Parkinson's disease.

NIH Plans Genetic Testing Registry

The registry, which is slated for 2011, will be a resource of information on the availability, utility, and validity of genetic tests.

NCI-Led Team Explores Predictive Use of Breast Cancer Risk Variants

A NEJM study suggests 10 breast cancer risk variants add little information to non-genetic risk prediction models.

Nanosphere Respiratory Panel Categorized as Moderate Complexity

The Verigene SP respiratory virus panel is the first of Nanosphere's test to get the moderate complexity designation.

Transcription Factor Binding Differences Detected in Humans, Yeast

Researchers from the US, UK, and Germany used chromatin immunoprecipitation sequencing to identify and begin characterizing transcription factor binding variability in humans and yeast.

OGT Signs up Kreatech as France Distributor

Kreatech will distribute the CytoSure array product line for cytogenetics and molecular biology applications.